kp PMD is investing $25 million over the next few years in technology and processes to ensure it delivers innovative, functional and safe products for customers. This investment in North America complements earlier announcements by kp this year, highlighting capacity expansions in Switzerland and Brazil. kp plans for the new capability in North America to be operational in 2020.
“Our significant expansion plans reflect our dedication to servicing customers’ needs now, and in the future,” says Tracey Peacock, president of kp PMD. “The additional coating and laminating capability suitable for the production of Pentapharm® and Pentamed® packaging films will serve the North American pharmaceutical and medical-device industry. We are excited to support the growing high-barrier product segments by investing in best-in-class coating and laminating capabilities, enabling new performance levels in barrier protection.”